# Contributions to Hypertension With Androgen Deprivation Therapy

> **NCT05700903** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 10 (actual)

## Conditions studied

- Androgen Deprivation Therapy
- Prostate Cancer
- Hypertension
- Autonomic Dysfunction
- Renal Disease

## Interventions

- **DRUG:** Gonadotropin Releasing Hormone Agonists (GNRH)
- **DRUG:** Androgen receptor (AR) inhibitor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05700903
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-20
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-07-16
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700903, "Contributions to Hypertension With Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05700903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*